← Suzhou Huazhijie Telecom overview

Suzhou Huazhijie Telecom vs Ningbo Ronbay New Energy Tech: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Suzhou Huazhijie Telecom Co (603400.CG)

Q3 2026
▲2▼1

Huazhijie pivots to chip testing with Geliming acquisition

  • Weak first-half results Huazhijie's first-half 2026 net profit fell 46.78% and revenue dropped 3.60%, showing its core telecom components business is under pressure. Weak earnings weigh on the stock because investors see no near-term growth from the existing business.

    This explains the weak fundamental backdrop before the acquisition news.

  • Acquisition of Geliming announced On September 14, Huazhijie said it would buy 100% of Geliming Electronics, a semiconductor test fixture maker, using shares and cash. The stock hit its daily limit that day and trading was suspended, as investors bet the deal moves Huazhijie into a faster-growing chip-related business.

    This is the main new event that changed the company's story and drove the stock.

  • Deal terms and trading resumption On September 29, Huazhijie detailed the plan to buy 83.51% of Geliming at 39.08 yuan per share, a 28.5% discount to the last close, and said trading resumes September 30. The deal expands its precision components business into semiconductor testing, but the company warned of insider-trading risk that could delay or cancel it.

    This gives the concrete terms and the key risk that will shape the stock when it reopens.

August 2026
▲2▼1

Huazhijie pivots to chip testing with Geliming acquisition

  • Weak first-half results Huazhijie's first-half 2026 net profit fell 46.78% and revenue dropped 3.60%, showing its core telecom components business is under pressure. Weak earnings weigh on the stock because investors see no near-term growth from the existing business.

    This explains the weak fundamental backdrop before the acquisition news.

  • Acquisition of Geliming announced On September 14, Huazhijie said it would buy 100% of Geliming Electronics, a semiconductor test fixture maker, using shares and cash. The stock hit its daily limit that day and trading was suspended, as investors bet the deal moves Huazhijie into a faster-growing chip-related business.

    This is the main new event that changed the company's story and drove the stock.

  • Deal terms and trading resumption On September 29, Huazhijie detailed the plan to buy 83.51% of Geliming at 39.08 yuan per share, a 28.5% discount to the last close, and said trading resumes September 30. The deal expands its precision components business into semiconductor testing, but the company warned of insider-trading risk that could delay or cancel it.

    This gives the concrete terms and the key risk that will shape the stock when it reopens.

Latest
▲2▼1

Huazhijie pivots to chip testing with Geliming acquisition

  • Weak first-half results Huazhijie's first-half 2026 net profit fell 46.78% and revenue dropped 3.60%, showing its core telecom components business is under pressure. Weak earnings weigh on the stock because investors see no near-term growth from the existing business.

    This explains the weak fundamental backdrop before the acquisition news.

  • Acquisition of Geliming announced On September 14, Huazhijie said it would buy 100% of Geliming Electronics, a semiconductor test fixture maker, using shares and cash. The stock hit its daily limit that day and trading was suspended, as investors bet the deal moves Huazhijie into a faster-growing chip-related business.

    This is the main new event that changed the company's story and drove the stock.

  • Deal terms and trading resumption On September 29, Huazhijie detailed the plan to buy 83.51% of Geliming at 39.08 yuan per share, a 28.5% discount to the last close, and said trading resumes September 30. The deal expands its precision components business into semiconductor testing, but the company warned of insider-trading risk that could delay or cancel it.

    This gives the concrete terms and the key risk that will shape the stock when it reopens.

Ningbo Ronbay New Energy Tech Ltd (688005.CG)

Q3 2026
▲3

Ronbay Swings to Profit, Expands Sodium-Ion Capacity

  • First-half profit turnaround Ronbay returned to profit with 109 million yuan net income, versus a loss last year, as revenue rose 39.57% on higher shipments and better overseas plant use. This shows the core business is recovering, which supports the stock price.

    This is the key financial result that directly improves investor confidence and valuation.

  • Sodium-ion cathode expansion Ronbay plans to invest 4.723 billion yuan in a 300,000-tonne sodium-ion cathode plant, with first phase starting August 2026. Sodium-ion products are already shipping at scale, positioning the company for future growth beyond lithium.

    This major investment signals a new growth engine and long-term capacity leadership.

  • Lithium manganese iron phosphate full production The company's LMFP business is running at full capacity with all output sold, and sales rose about 50% year-on-year. This high-demand product line boosts revenue and shows strong market acceptance.

    It highlights a key product driving current sales and profitability.

  • Industry-wide capacity expansion risk Rising material prices have triggered about 30 billion yuan of new projects across the battery supply chain, including Ronbay's. While this meets current demand, it could lead to oversupply and margin pressure later, a risk to watch.

    It provides a balanced view of the competitive and pricing risks from collective expansion.

July 2026
▲3

Ronbay Swings to Profit, Expands Sodium-Ion Capacity

  • First-half profit turnaround Ronbay returned to profit with 109 million yuan net income, versus a loss last year, as revenue rose 39.57% on higher shipments and better overseas plant use. This shows the core business is recovering, which supports the stock price.

    This is the key financial result that directly improves investor confidence and valuation.

  • Sodium-ion cathode expansion Ronbay plans to invest 4.723 billion yuan in a 300,000-tonne sodium-ion cathode plant, with first phase starting August 2026. Sodium-ion products are already shipping at scale, positioning the company for future growth beyond lithium.

    This major investment signals a new growth engine and long-term capacity leadership.

  • Lithium manganese iron phosphate full production The company's LMFP business is running at full capacity with all output sold, and sales rose about 50% year-on-year. This high-demand product line boosts revenue and shows strong market acceptance.

    It highlights a key product driving current sales and profitability.

  • Industry-wide capacity expansion risk Rising material prices have triggered about 30 billion yuan of new projects across the battery supply chain, including Ronbay's. While this meets current demand, it could lead to oversupply and margin pressure later, a risk to watch.

    It provides a balanced view of the competitive and pricing risks from collective expansion.

Latest
▲3

Ronbay Swings to Profit, Expands Sodium-Ion Capacity

  • First-half profit turnaround Ronbay returned to profit with 109 million yuan net income, versus a loss last year, as revenue rose 39.57% on higher shipments and better overseas plant use. This shows the core business is recovering, which supports the stock price.

    This is the key financial result that directly improves investor confidence and valuation.

  • Sodium-ion cathode expansion Ronbay plans to invest 4.723 billion yuan in a 300,000-tonne sodium-ion cathode plant, with first phase starting August 2026. Sodium-ion products are already shipping at scale, positioning the company for future growth beyond lithium.

    This major investment signals a new growth engine and long-term capacity leadership.

  • Lithium manganese iron phosphate full production The company's LMFP business is running at full capacity with all output sold, and sales rose about 50% year-on-year. This high-demand product line boosts revenue and shows strong market acceptance.

    It highlights a key product driving current sales and profitability.

  • Industry-wide capacity expansion risk Rising material prices have triggered about 30 billion yuan of new projects across the battery supply chain, including Ronbay's. While this meets current demand, it could lead to oversupply and margin pressure later, a risk to watch.

    It provides a balanced view of the competitive and pricing risks from collective expansion.